Cargando…
Decreased salivary lactoferrin levels are specific to Alzheimer's disease
BACKGROUND: Evidences of infectious pathogens in Alzheimer's disease (AD) brains may suggest a deteriorated innate immune system in AD pathophysiology. We previously demonstrated reduced salivary lactoferrin (Lf) levels, one of the major antimicrobial proteins, in AD patients. METHODS: To asses...
Autores principales: | González-Sánchez, Marta, Bartolome, Fernando, Antequera, Desiree, Puertas-Martín, Veronica, González, Pilar, Gómez-Grande, Adolfo, Llamas-Velasco, Sara, Herrero-San Martín, Alejandro, Pérez-Martínez, David, Villarejo-Galende, Alberto, Atienza, Mercedes, Palomar-Bonet, Miriam, Cantero, Jose Luis, Perry, George, Orive, Gorka, Ibañez, Borja, Bueno, Hector, Fuster, Valentin, Carro, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378957/ https://www.ncbi.nlm.nih.gov/pubmed/32586758 http://dx.doi.org/10.1016/j.ebiom.2020.102834 |
Ejemplares similares
-
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
por: Carro, Eva, et al.
Publicado: (2017) -
Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease
por: Bartolome, Fernando, et al.
Publicado: (2021) -
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
por: Bartolomé, Fernando, et al.
Publicado: (2022) -
Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
por: Antequera, Desiree, et al.
Publicado: (2021) -
Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
por: Blanco-Palmero, Víctor Antonio, et al.
Publicado: (2021)